Mackenzie Financial
INFI

Mackenzie Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Mackenzie Financial’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,226
Closed -$24K – 1612
2022
Q3 		$24K Sell
20,226
-6,956
-26% -$7.5K ﹤0.01% 1402
2022
Q2 		$17K Buy
+27,182
New +$20.9K ﹤0.01% 1443

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Mackenzie Financial's INFI Position: Q4 2022 in Review

Mackenzie Financial sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 20,226 shares — an estimated $24K sold.

Mackenzie Financial first reported a position in INFI in Q2 2022 and held it in 2 quarters. The position peaked at $24K in Q3 2022. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Mackenzie Financial reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Mackenzie Financial sold 20,226 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $24K.
  • Mackenzie Financial first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2022 and held it in 2 quarters.
  • Mackenzie Financial's Infinity Pharmaceuticals, Inc. position peaked at $24K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Mackenzie Financial's 13F filing for Q4 2022, filed 14 Feb 2023.